Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:1145-1151

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hobbs, W. J. C.
Right arrow Articles by Garratt, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hobbs, W. J. C.
Right arrow Articles by Garratt, C. J.
Related Collections
Right arrow Electrophysiology
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Remodeling

(Circulation. 2000;101:1145.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Reversal of Atrial Electrical Remodeling After Cardioversion of Persistent Atrial Fibrillation in Humans

W. Julian C. Hobbs, MB; Simon Fynn, MB; Derick M. Todd, MB; Peter Wolfson, MB; Mike Galloway, BS; Clifford J. Garratt, DM

From the Manchester Heart Centre, Manchester Royal Infirmary, Manchester, UK.

Correspondence to Clifford J. Garratt, DM, Manchester Heart Centre, Oxford Rd, Manchester M13 9WL, UK. E-mail Clifford.Garratt{at}mhc.cmht.nwest.nhs.uk

Background—Although atrial electrical remodeling has been studied extensively in animal models, the reversibility of this phenomenon after termination of clinical atrial fibrillation (AF) has not been demonstrated. We aimed to examine this important question of reversibility by using AF cycle length (AFCL) and coupling intervals of atrial premature beats after cardioversion as measures of atrial refractoriness.

Methods and Results—We measured AFCL at the right atrial appendage and distal coronary sinus before attempting internal cardioversion in 39 patients with persistent AF. Patients were monitored by daily transtelephonic recordings after discharge and admitted rapidly for repeat internal cardioversion if there was spontaneous AF recurrence. Measurements of AFCL were repeated immediately before repeat cardioversions in the 17 patients who had recurrence of AF. There was an increase in AFCL from the initial cardioversion to that measured at the time of first AF recurrence at both the right atrial appendage (161±22 vs 167±26 ms, P=0.05) and distal coronary sinus (162±20 vs 168±22 ms, P=0.01) sites. The magnitude of increase in AFCL was positively correlated with duration of sinus rhythm before AF recurrence (r=0.524, P=0.001). Other measures of refractoriness (shortest coupling interval of atrial premature beats and directly measured refractory periods after cardioversion) also increased from initial to subsequent cardioversions.

Conclusions—These findings demonstrate that changes in atrial electrophysiology associated with chronic AF in humans are reversible after cardioversion and that the extent of this reversal is dependent on the duration of sinus rhythm after cardioversion.


Key Words: fibrillation • remodeling • cardioversion




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. E.W. Hemels, T. Van Noord, H. J.G.M. Crijns, D. J. Van Veldhuisen, N. J.G.M. Veeger, H. A. Bosker, A. C.P. Wiesfeld, M. P. Van den Berg, A. V. Ranchor, and I. C. Van Gelder
Verapamil Versus Digoxin and Acute Versus Routine Serial Cardioversion for the Improvement of Rhythm Control for Persistent Atrial Fibrillation
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1001 - 1009.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J P Bourke, A Dunuwille, D O'Donnell, S Jamieson, and S S Furniss
Pulmonary vein ablation for idiopathic atrial fibrillation: six month outcome of first procedure in 100 consecutive patients
Heart, January 1, 2005; 91(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G. Q. Villani, M. F. Piepoli, and A. Capucci
Reproducibility of internal atrial defibrillation threshold in paroxysmal and persistent atrial fibrillation
Europace, January 1, 2004; 6(4): 267 - 272.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
T. Van Noord, R. G. Tieleman, H. A. Bosker, T. Kingma, D. J. Van Veldhuisen, H. J.G.M Crijns, and I. C. Van Gelder
Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension
Europace, January 1, 2004; 6(4): 343 - 350.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.C. Geller, S. Reek, C. Timmermans, T. Kayser, H.-F. Tse, C. Wolpert, W. Jung, A.J. Camm, C.-P. Lau, H. J.J. Wellens, et al.
Treatment of atrial fibrillation with an implantable atrial defibrillator -- long term results
Eur. Heart J., December 1, 2003; 24(23): 2083 - 2089.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Schuetz, C.J. Schulze, K.K. Sarvanakis, H. Mair, H. Plazer, E. Kilger, B. Reichart, and S.M. Wildhirt
Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial
Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 475 - 480.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
G. C. Gronefeld and S. H. Hohnloser
Heart Failure Complicated by Atrial Fibrillation: Mechanistic, Prognostic, and Therapeutic Implications
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 107 - 113.
[Abstract] [PDF]


Home page
EuropaceHome page
B. Gorenek, G. Kudaiberdieva, O. Goktekin, Y. Cavusoglu, A. Birdane, A. Unalir, N. Ata, and B. Timuralp
Long-short sequence may predict immediate recurrence of atrial fibrillation after external cardioversion
Europace, January 1, 2003; 5(1): 11 - 16.
[Abstract] [PDF]


Home page
Eur Heart JHome page
S. P. Fynn and C. J. Garratt
The effectiveness of serial cardioversion therapy for recurrence of atrial fibrillation
Eur. Heart J., October 1, 2002; 23(19): 1487 - 1489.
[Full Text] [PDF]


Home page
CirculationHome page
K. Fan, K. L. Lee, W.-H. Chow, E. Chau, and C.-P. Lau
Internal Cardioversion of Chronic Atrial Fibrillation During Percutaneous Mitral Commissurotomy: Insight Into Reversal of Chronic Stretch-Induced Atrial Remodeling
Circulation, June 11, 2002; 105(23): 2746 - 2752.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Shinagawa, Y.-F. Shi, J.-C. Tardif, T.-K. Leung, and S. Nattel
Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs
Circulation, June 4, 2002; 105(22): 2672 - 2678.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Allessie, J. Ausma, and U. Schotten
Electrical, contractile and structural remodeling during atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 230 - 246.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, R. H. Henning, H. H. Kampinga, I. C. Van Gelder, and H. J.G.M. Crijns
Molecular mechanisms of remodeling in human atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 315 - 324.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Nattel
Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?
Cardiovasc Res, May 1, 2002; 54(2): 347 - 360.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Korte, M. Niehaus, G. Borchert, and J. Tebbenjohanns
Significant prolongation of atrial monophasic action potential duration: short-term reverse electrophysiological changes after internal cardioversion of atrial fibrillation
Cardiovasc Res, March 1, 2002; 53(4): 944 - 951.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Shinagawa, D. Li, T. K. Leung, and S. Nattel
Consequences of Atrial Tachycardia-Induced Remodeling Depend on the Preexisting Atrial Substrate
Circulation, January 15, 2002; 105(2): 251 - 257.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. J Workman, K. A Kane, and A. C Rankin
The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation
Cardiovasc Res, November 1, 2001; 52(2): 226 - 235.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.P Fynn, D.M Todd, W.J.C Hobbs, K.L Armstrong, and C.J Garratt
Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation. A manifestation of atrial electrical remodelling in humans?
Eur. Heart J., October 1, 2001; 22(19): 1822 - 1834.
[Abstract] [PDF]


Home page
NEJMHome page
R. H. Falk
Atrial Fibrillation
N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078.
[Full Text] [PDF]


Home page
EuropaceHome page
H. J. G. M. Crijns
Internal cardioversion as a first-line method of cardioversion?
Europace, January 1, 2001; 3(1): 2 - 3.
[PDF]


Home page
QJMHome page
C.J. Garratt and S.P. Fynn
Atrial electrical remodelling and atrial fibrillation
QJM, September 1, 2000; 93(9): 563 - 565.
[Full Text] [PDF]